News
Ohtuvayre, an innovative first-in-class PDE3 and PDE4 inhibitor, offers a needed, unique, important advancement in the treatment of COPD.
Hosted on MSN5mon
Don’t Combine These COPD Medicines - MSN
Classes of COPD Inhaler Medications There are different classes of inhaled medications used in the treatment of COPD. Among them: ...
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade ...
12d
News-Medical.Net on MSNCOPD care pathways improve hospital outcomes and standardize treatment
Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved standardization of care, ...
Using a care pathway focused on chronic obstructive pulmonary disease (COPD) can lead to shorter hospital stays, increased referrals to pulmonary rehabilitation, and improved standardization of care, ...
People with schizophrenia are more likely to develop chronic obstructive pulmonary disease (COPD), suggesting a possible ...
Chronic obstructive pulmonary disease, or COPD, is a group of lung diseases with no cure. CNN wellness expert Dr. Leana Wen ...
This novel, first-in-class treatment addresses an important unmet need for COPD patients persistently symptomatic based on its unique combination of bronchodilatory and non-steroidal anti-inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results